Orexigen (OREX -12%) adds to Friday's 30% drubbing after announcing its obesity-drug program is...

|About: Orexigen Therapeutics, Inc. (OREX)|By:, SA News Editor

Orexigen (OREX -12%) adds to Friday's 30% drubbing after announcing its obesity-drug program is being put on hold indefinitely. The stock is now trading at lows not seen since April 2009.